Skin diseases in laboratory mice: Approaches to drug target identification and efficacy screening

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A large variety of mouse models for human skin and adnexa diseases are readily available from investigators and vendors worldwide. While the skin is an obvious organ to observe lesions and their response to therapy, actually treating and monitoring progress in mice can be challenging. This chapter provides an overview on how to use the laboratory mouse as a preclinical tool to evaluate efficacy of a new compound or test potential new uses for a compound approved for use for treating an unrelated disease. Basic approaches to handling mice, applying compounds, and quantifying effects of the treatment are presented. © 2010 Humana Press, a part of Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Sundberg, J. P., Silva, K. A., McPhee, C., & King, L. E. (2010). Skin diseases in laboratory mice: Approaches to drug target identification and efficacy screening. Methods in Molecular Biology, 602, 193–213. https://doi.org/10.1007/978-1-60761-058-8_12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free